PReS13-SPK-1129: Biologic therapies in SLE

por Isenberg, DA
Publicado 2013

Cancer complicating systemic lupus erythematosus – a dichotomy emerging from a nested case-control study

por Dey, D, Kenu, E, Isenberg, DA
Publicado 2013

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus – report of 17 cases and review of the literature

por Hofmann, SC, Leandro, MJ, Morris, SD, Isenberg, DA
Publicado 2013

Follow up study of B-lymphocyte depletion in the treatment of patients with systemic lupus erythematosus

por Leandro, MJ, Edwards, JCW, Ehrenstein, MR, Cambridge, G, Isenberg, DA
Publicado 2005

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry’s disease

por Nandagudi, A, Jury, EC, Alonzi, D, Butters, TD, Hughes, S, Isenberg, DA
Publicado 2013

Lymphoma risk in systemic lupus: effects of treatment versus disease activity

por Clarke, AE, Bernatsky, S, Costenbader, KH, Urowitz, MB, Gladman, DD, Fortin, PR, Petri, M, Manzi, S, Isenberg, DA, Rahman, A, Wallace, D, Gordon, C, Peschken, C, Dooley, MA, Ginzler, EM, Aranow, C, Edworthy, SM, Nived, O, Jacobsen, S, Ruiz-Irastorza, G, Yelin, E, Barr, SG, Criswell, L, Sturfelt, G, Dreyer, L, Blanco, I, Gottesman, L, Feldman, CH, Ramsey-Goldman, R
Publicado 2012